Latest news
BioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSciAllSci · Fri, 07 Aug 2026 16:28:01 GMTReplimune secures accelerated approval for oncolytic viral therapy Tudriqev - AllSciAllSci · Fri, 07 Aug 2026 13:34:42 GMTTakeda ushers in the orexin era with landmark FDA approval - AllSciAllSci · Thu, 06 Aug 2026 09:28:45 GMTLexeo's PKP2 cardiomyopathy gene therapy adds RMAT status - AllSciAllSci · Thu, 06 Aug 2026 09:07:22 GMTModerna's mFlusiva becomes first mRNA influenza vaccine in US - AllSciAllSci · Thu, 06 Aug 2026 08:57:48 GMTGilead raises full-year guidance on 8% Q2 sales growth, eyes three near-term regulatory approvals - AllSciAllSci · Wed, 05 Aug 2026 14:17:35 GMTArrowhead acquires FDA priority review voucher for plozasiran's severe hypertriglyceridemia expansion - AllSciAllSci · Wed, 05 Aug 2026 09:58:01 GMTFDA grants Fast Track designation to XellSmart's off-the-shelf Parkinson's cell therapy XS411 - AllSciAllSci · Tue, 04 Aug 2026 14:35:12 GMT